Metagenomic analysis reveals crosstalk between gut microbiota and glucose-lowering drugs targeting the gastrointestinal tract in Chinese patients with type 2 diabetes: a 6 month, two-arm randomised trial

AIMS/HYPOTHESIS: The use of oral glucose-lowering drugs, particularly those designed to target the gut ecosystem, is often observed in association with altered gut microbial composition or functional capacity in individuals with type 2 diabetes. The gut microbiota, in turn, plays crucial roles in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiuying, Ren, Huahui, Zhao, Cuiling, Shi, Zhun, Qiu, Li, Yang, Fangming, Zhou, Xianghai, Han, Xueyao, Wu, Kui, Zhong, Huanzi, Li, Yufeng, Li, Junhua, Ji, Linong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477956/
https://www.ncbi.nlm.nih.gov/pubmed/35930018
http://dx.doi.org/10.1007/s00125-022-05768-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477956/
https://www.ncbi.nlm.nih.gov/pubmed/35930018
http://dx.doi.org/10.1007/s00125-022-05768-5

Ejemplares similares